Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2215-2217

  Hibi, Kenji ^a   Goto, Tetsuhiro ^a   Mizukami, Hiroki ^a   Kitamura, Yo Hei ^a   Sakuraba, Kazuma ^a   Sakata, Makiko ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

CDH3; Colorectal cancer; Quantitative methylation specific PCR

Indexed keywords

P CADHERIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SIZE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DEMETHYLATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CASE-CONTROL STUDIES; COLON; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 67650892061     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
2. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preesinger AC, Smith KJ, Su LK, Kinzler KW and Vogelsteen B: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991. (Pubitemid 21917200)
3. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
4. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996. (Pubitemid 26048601)
5. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K and Takagi H: Alternative splicing of the FHIT gene in colorectal cancer. Jpn J Cancer Res 88: 385-388, 1997.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
7. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M and Abe O: Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49: 2128-2133, 1989. (Pubitemid 19106526)
8. Sanders DS, Bruton R, Darnton SJ, Casson AG, Hanson I, Williams HK and Jankowski J: Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer 79: 573-579, 1998. (Pubitemid 28549467)
9. Shimoyama Y and Hirohashi S: Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 51: 2185-2192, 1991.
10. Palacios J, Benito N, Pizarro A, Suarez A, Espada J, Cano A and Gamallo C: Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features. Am J Pathol 146: 605-612, 1995.
11. Bryan R, Atherfold P, Yeo Y, Jones LJ, Harrison RF, Wallace DMA and Jankowski JA: Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 215: 184-194, 2008. (Pubitemid 351786037)
12. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H, Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano S, Kondo S, Katoh H, Nakamura Y and Katagiri T: Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene 23: 2385-2400, 2004. (Pubitemid 38496794)
13. Milicic A, Harrison LA, Goodlad RA, Hardy RG, Nicholson AN, Presz M, Sieber O, Santander S, Pringle JH, Mandir N, East P, Obszynska J, Sanders S, Piazuelo E, Shaw J, Harrison R, Tomlinson IA, McDonald SAC, Wright NA and Jankowski JAZ: Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res 68: 7760-7768, 2008.
14. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001.
15. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
16. Yamazaki T, Hibi K, Takase T, Tezel E, Nakayama H, Kasai Y, Ito K, Akiyama S, Nagasaka T and Nakao A: PGP9.5 as a marker for invasive colorectal cancer. Clin Cancer Res 8: 192-195, 2002. (Pubitemid 34101477)
17. Mizukami H, Shirahata A, Goto T, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y and Hibi K: PGP9.5 methylation as a marker for metastatic colorectal cancer. Anticancer Res 28: 2697-2700, 2008.